Abstract
BackgroundMultiple myeloma (MM) patients presenting with anaemia as their sole clinical manifestation are rare and not fully defined. MethodsRetrospective multi-site study comparing the characteristics and outcome of MM patients with anaemia only with matched patients, presenting with multi-organ disease. ResultsAnaemia-only patients had a higher percentage of bone marrow monoclonal plasma cells group (median 60% [IQR 42−80%] vs. 37% [IQR 17–65%], respectively; p < 0.001), and a lower responsiveness to treatment (≥VGPR rates were 54% vs 74%, p = 0.049). Median survival in anaemia only patients was 65.9 ± 6.9 vs 83.4 ± 8.8 months in matched control patients (P = n.s). ConclusionsMM patients presenting with anaemia only represents a unique, potentially less favorable population.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
